Vanguard Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.76M | Sell |
|
|||||
|
2025
Q1 | $8.62M | Sell |
|
|||||
|
2024
Q4 | $15.7M | Sell |
|
|||||
|
2024
Q3 | $26.8M | Buy |
|
|||||
|
2024
Q2 | $23.6M | Sell |
|
|||||
|
2024
Q1 | $33.7M | Sell |
|
|||||
|
2023
Q4 | $15.3M | Buy |
|
|||||
|
2023
Q3 | $12.2M | Buy |
|
|||||
|
2023
Q2 | $15.1M | Sell |
|
|||||
|
2023
Q1 | $11.4M | Buy |
|
|||||
|
2022
Q4 | $11M | Buy |
|
|||||
|
2022
Q3 | $27.7M | Sell |
|
|||||
|
2022
Q2 | $29.2M | Buy |
|
|||||
|
2022
Q1 | $21.3M | Sell |
|
|||||
|
2021
Q4 | $29.5M | Buy |
|
|||||
|
2021
Q3 | $51.5M | Buy |
|
|||||
|
2021
Q2 | $55.3M | Buy |
|
|||||
|
2021
Q1 | $48.3M | Buy |
|
|||||
|
2020
Q4 | $73.3M | Buy |
|
|||||
|
2020
Q3 | $47.8M | Buy |
|
|||||
|
2020
Q2 | $53.6M | Buy |
|
|||||
|
2020
Q1 | $28.2M | Buy |
|
|||||
|
2019
Q4 | $33M | Buy |
|
|||||
|
2019
Q3 | $19.4M | Buy |
|
|||||
|
2019
Q2 | $11.2M | Buy |
|
|||||
|
2019
Q1 | $7.46M | Buy |
|
|||||
|
2018
Q4 | $5.23M | Buy |
|
|||||
|
2018
Q3 | $2.26M | Buy |
|